Meet with BIOVECTRA at BPI West 2024
San Diego, California | March 11-18, 2024
Schedule a meeting with us at BPI West and discover how BIOVECTRA can help with your mRNA manufacturing needs.
BIOVECTRA's state-of-the-art Biomanufacturing and Vaccine Center has the:
- Capability to develop and manufacture plasmid DNA, mRNA, LNP formulations and fill/finish
- With scales ranging from 300 mL to 30L, we have the ability to produce up to 160 million doses of mRNA vaccines per year
- Capacity to prepare and package 70 million fill/finish doses per year for commercial distribution
BIOVECTRA is a North American CDMO specializing in the clinical-to-commercial scale production of high-quality regulated APIs and intermediates, including:
- Fermentation & Biologics
- Synthesis & Purification Small Molecules
- Highly potent APIs
- Bioreagents
- pDNA, mRNA & LNP
- Fill/Finish
Our team – backed by 50+ years of experience – looks forward to the opportunity to put our flexible, innovative manufacturing solutions at your disposal.
|
Schedule a meeting with us and discover how we can support your
projects and solve your most complex challenges.
|
